NSECertificate under SEBI (Depositories and Participants) Regulations, 20187 Jul 2026 · 7 Jul 2026, 03:28 pm
Certificate under SEBI (Depositories and Participants) Regulations, 2018
Aarti Pharmalabs Limited · AARTIPHARM
✦ AI Summary
Aarti Pharmalabs Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018, confirming the dematerialisation of securities and listing on stock exchanges.
Analysis Scores
Earnings Impact5/10
Growth Catalyst3/10
Governance Concern2/10
Regulatory Risk1/10
Balance Sheet Risk4/10
Liquidity Impact6/10
Market Sentiment5/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Aarti Pharmalabs Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018
Attachments (1)
📄pdf
Download →
AARTIPHARMA_07072026152809_AARTIPHARM_74_5_signed.pdf
View document text
July 07, 2026
To, To,
Listing/ Compliance Department Listing/ Compliance Department
BSE LTD. National Stock Exchange of India Limited
Phiroze Jeejeebhoy Towers, “Exchange Plaza”, Plot No. C/1,
Dalal Street, G Block, Bandra Kurla Complex
Mumbai - 400 001 Bandra (E), Mumbai – 400 051
SCRIP CODE: 543748 SYMBOL: AARTIPHARM
Dear Sir/Madam,
Sub: Certificate under Regulation 74(5) of the SEBI
(Depositories and Participants) Regulations, 2018
Please find enclosed herewith a Certificate under Regulation 74(5) of the SEBI (Depositories and
Participants) Regulations, 2018 for the quarter ended June 30, 2026 received from MUFG Intime
India Private Limited, Registrar and Share Transfer Agent of our Company.
Please take the same on your records.
Thanking you,
Yours faithfully,
For AARTI PHARMALABS LIMITED
JEEVAN MONDKAR
COMPANY SECRETARY AND LEGAL HEAD
ICSI M. NO. A22565
Encl. a/a.
MUFG Intime India Private Limited
(Formerly Link Intime India Private Limited)
CIN: U67190MH1999PTC118368
Registered Address:
C-101, Embassy 247, L.B.S. Marg,
Vikhroli (West), Mumbai - 400083.
Tel: +91 22 4918 6000
www.in.mpms.mufg.com
Date : 01-07-2026
The Compliance Officer/ Company Secretary
AARTI PHARMALABS LIMITED
PLOT NO 22/C/1 & 22/C/2, 1ST PHASE,
GIDC, VAPI,
VALSAD
GUJARAT
VALSAD
PINCODE : 396195
Sub : Confirmation Certificate under Regulation 74(5) of Securities and Exchange Board of India (Depositories and
Participants) Regulations, 2018.
Dear Sir/Madam,
In reference to the above captioned regulation, we hereby confirm that the securities received from the depository participants for
dematerialisation during the quarter ended 30th June 2026, were confirmed (accepted/rejected) to the depositories by us and that
securities comprised in the said certificates have been listed on the stock exchanges where the earlier issued securities are listed.
We hereby also confirm that the security certificates received for dematerialisation have been confirmed/rejected and the security
certificates received were mutilated and cancelled after due verification by the depository participant and the name of the
depositories have been substituted in the register of members as the registered owner within the prescribed timelines. We request
you to kindly take note of the above in your records.
Thanking you,
Yours faithfully,
For MUFG Intime India Private Limited
(Formerly Link Intime India Private Limited)
Ashok Shetty
Sr. Vice President-Corporate Registry
MUFG Intime India Private Limited
A part of MUFG Corporate Markets, a division of MUFG Pension & Market Services